Biomea’s Novel Diabetes Candidate Placed On FDA Hold

 
• By Joseph Haas
  
Delay
Biomea's diabetes candidate ran into a delay as the FDA placed two trials on hold • Source: Shutterstock

More from Clinical Trials

More from R&D